Climb Bio to Present at the 24th Annual Needham Virtual Healthcare Conference
Climb Bio (Nasdaq: CLYM) has announced its participation in the upcoming 24th Annual Needham Virtual Healthcare Conference. The company's executive team will be presenting at this virtual event, which is scheduled to take place from April 7-10, 2025.
The presentation is specifically scheduled for April 10, 2025, at 8:45 a.m. ET. The format will include both a formal presentation and one-on-one investor meetings, providing opportunities for direct engagement with the company's leadership.
Climb Bio (Nasdaq: CLYM) ha annunciato la sua partecipazione alla prossima 24ª Conferenza Virtuale Annuale sulla Salute di Needham. Il team esecutivo dell'azienda presenterà a questo evento virtuale, che si terrà dal 7 al 10 aprile 2025.
La presentazione è programmata specificamente per il 10 aprile 2025, alle 8:45 a.m. ET. Il formato includerà sia una presentazione formale che incontri individuali con gli investitori, offrendo opportunità di interazione diretta con la leadership dell'azienda.
Climb Bio (Nasdaq: CLYM) ha anunciado su participación en la próxima 24ª Conferencia Virtual Anual de Salud de Needham. El equipo ejecutivo de la empresa presentará en este evento virtual, que está programado para llevarse a cabo del 7 al 10 de abril de 2025.
La presentación está programada específicamente para el 10 de abril de 2025, a las 8:45 a.m. ET. El formato incluirá tanto una presentación formal como reuniones individuales con inversores, brindando oportunidades para la interacción directa con el liderazgo de la empresa.
Climb Bio (Nasdaq: CLYM)는 다가오는 제24회 니드햄 가상 의료 컨퍼런스에 참여한다고 발표했습니다. 회사의 경영진 팀은 2025년 4월 7일부터 10일까지 열리는 이 가상 이벤트에서 발표할 예정입니다.
발표는 2025년 4월 10일 오전 8시 45분 ET로 특별히 예정되어 있습니다. 형식은 공식 발표와 1대1 투자자 회의를 포함하여 회사의 리더십과 직접 소통할 수 있는 기회를 제공합니다.
Climb Bio (Nasdaq: CLYM) a annoncé sa participation à la prochaine 24e Conférence Virtuelle Annuelle sur la Santé de Needham. L'équipe exécutive de l'entreprise présentera à cet événement virtuel, qui est prévu du 7 au 10 avril 2025.
La présentation est spécifiquement prévue pour le 10 avril 2025 à 8h45 ET. Le format comprendra à la fois une présentation formelle et des réunions individuelles avec les investisseurs, offrant des opportunités d'engagement direct avec la direction de l'entreprise.
Climb Bio (Nasdaq: CLYM) hat seine Teilnahme an der bevorstehenden 24. jährlichen virtuellen Gesundheitskonferenz von Needham angekündigt. Das Führungsteam des Unternehmens wird auf dieser virtuellen Veranstaltung präsentieren, die vom 7. bis 10. April 2025 stattfinden wird.
Die Präsentation ist speziell für den 10. April 2025 um 8:45 Uhr ET angesetzt. Das Format umfasst sowohl eine formelle Präsentation als auch Einzelgespräche mit Investoren, die Möglichkeiten für direkte Interaktionen mit der Unternehmensführung bieten.
- None.
- None.
WELLESLEY, Mass., March 27, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM) today announced that members of its executive team will participate at the 24th Annual Needham Healthcare Conference being held virtually April 7-10, 2025.
24th Annual Needham Virtual Healthcare Conference
Format: Presentation and one-on-one investor meetings
Date: April 10, 2025
Time: 8:45 a.m. ET
Webcast: Click here
About Climb Bio, Inc.
Climb Bio, Inc. is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. The Company’s pipeline includes, budoprutug, an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has potential to treat a broad range of B-cell mediated diseases, and CLYM116, an anti-APRIL monoclonal antibody currently in IND-enabling studies for IgA nephropathy. For more information, please visit climbbio.com.
Investors
Chris Brinzey
ICR Healthcare
chris.brinzey@icrhealthcare.com
339-970-2843
Media
Jon Yu
ICR Healthcare
jon.yu@icrhealthcare.com
475-395-5375
